Dr NTR University Of Health Sciences Informs On Free Exit For Phase 1 MBBS Candidates, Details

Published On 2022-11-17 03:45 GMT   |   Update On 2022-11-17 03:45 GMT

Andhra Pradesh : Through a recent notice, Dr NTR University of Health Sciences has informed about the free exit option for the candidates and Principals of Private Medical Colleges about the UG (Medical) Phase -I.a. Reported/Joined candidates of Phase-I are permitted to exit from the reported seat on or before 4.00 P.M. on 18.11.2022 and shall submit their requests to the Principal...

Login or Register to read the full article

Andhra Pradesh : Through a recent notice, Dr NTR University of Health Sciences has informed about the free exit option for the candidates and Principals of Private Medical Colleges about the UG (Medical) Phase -I.

a. Reported/Joined candidates of Phase-I are permitted to exit from the reported seat on or before 4.00 P.M. on 18.11.2022 and shall submit their requests to the Principal concerned. Such candidates will not be eligible for further rounds of counselling.

b. The candidates who have opted for Retain / Continue in the Phase-I reported seat/college under Competent Authority Quota are also eligible to avail free exit facility.

c. In that situation, the Principals shall return original certificates and entire Tuition fee and other fees, if any to the candidates immediately and shall freeze the latest data by 5.00 PM on 18.11.2022.

d. Thereafter, no candidate will be permitted to withdraw from the seat till the closure of admissions.

e. Candidates who have resigned from the Phase-I reported/joined seat before the said date will be considered as not reported/not joined and such vacated seats will be filled in Phase-II counselling as per rules.

f. After the said date, all Phase-I reported/joined candidates will be considered as a part of Phase-II and the Phase-II rules will apply on them as applicable for Phase-II of counselling and cannot resign the seat.

g. Phase-I Reported candidates who have not opted to exit from the Phase-I reported seat will be considered for Phase-II of counselling for upgradation/sliding as per the one-time options already exercised and will be considered as a part of Phase-II and same rules will apply on them as applicable for Phase-II of counselling and cannot resign the seat.

h. The candidates who have already opted to retain in the allotted seat of Phase-I (by submitting self-declaration) and who do not opt for free exit will not be considered for upgradation in next phase of counselling (as per the one time options already exercised), but will be retained in the existing seat and will be considered as a part of Phase-II (except for default sliding in the same college) and same rules will apply on them as applicable for Phase-II of counselling and cannot resign the seat.

i. As per the Notice 12021/01/2022-MEC, dt.12-07-2022 of DGHS, HM&FW Govt. of India, New Delhi, the joined candidates up to round 2 of AIQ or State Quota shall not be eligible to participate in the further rounds for All India Quota or for State Quota from the academic year 2022-23 onwards.

2. Discontinuation from the Course:

a. Reported Candidates who have not utilised the free exit facility as per the schedule cannot resign the seat during the course of admissions i.e from Phase-II counselling to till closure of admissions.

b. As per G.O.Ms.No.72, HM&FW (C1) Dept., dt.15-07-2019 if any candidate wants to withdraw from the course after the closure of admissions in the middle of the course such candidate has to submit his/her request through the Principal of the college concerned along with course discontinuation fee Rs.3,00,000/- for MBBS plus GST as applicable to the University by way of demand draft. 

To view the official Notice, Click here :  https://medicaldialogues.in/pdf_upload/freeexitmbbs-191213.pdf


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News